APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-inflammatory Therapeutics

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

Selected research

Market Structure

Global Anti-inflammatory Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026195 pages

Choose your research edition.

Industry ResearchAnti-inflammatory Therapeutics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-inflammatory Therapeutics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Anti-inflammatory Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-inflammatory Therapeutics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-inflammatory Therapeutics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

Report Includes

Read the full market overview

This report provides an overview of the global Anti-inflammatory Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-inflammatory Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-inflammatory Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Anti-inflammatory Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-inflammatory Therapeutics Segment by Company

AbbVie

Johnson & Johnson

Amgen Inc

AstraZeneca PLC

Pfizer, Inc

Novartis

Roche

Merck

Sanofi

GlaxoSmithKline

Sun Pharmaceutical Industries Ltd

TEVA

Anti-inflammatory Therapeutics Segment by Type

Anti-inflammatory Biologics

Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Corticosteroids

Others

Anti-inflammatory Therapeutics Segment by Application

Arthritis

Respiratory Diseases

Dermatology

Gastroenterology

Others

Anti-inflammatory Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Anti-inflammatory Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-inflammatory Therapeutics industry.

Chapter 3: Detailed analysis of Anti-inflammatory Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-inflammatory Therapeuticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Anti-inflammatory Biologics Table 3. Key Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Table 4. Key Players of Corticosteroids Table 3. Key Players of Others Table 4. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Arthritis Table 6. Key Players of Respiratory Diseases Table 7. Key Players of Dermatology Table 8. Key Players of Gastroenterology Table 9. Key Players of Others Table 10. Global Anti-inflammatory Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Anti-inflammatory Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Anti-inflammatory Therapeutics Market Share by Region (2021-2026) Table 13. Global Anti-inflammatory Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Anti-inflammatory Therapeutics Market Share by Region (2027-2032) Table 15. Anti-inflammatory Therapeutics Industry Trends Table 16. Anti-inflammatory Therapeutics Industry Drivers Table 17. Anti-inflammatory Therapeutics Industry Opportunities and Challenges Table 18. Anti-inflammatory Therapeutics Industry Restraints Table 19. Global Anti-inflammatory Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Anti-inflammatory Therapeutics Revenue Market Share by Company (2021-2026) Table 21. Global Anti-inflammatory Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Anti-inflammatory Therapeutics Key Company Head Office and Area Served Table 23. Global Anti-inflammatory Therapeutics Company, Product Type & Application Table 24. Global Anti-inflammatory Therapeutics Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Anti-inflammatory Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Anti-inflammatory Therapeutics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Anti-inflammatory Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Anti-inflammatory Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2021-2026) Table 31. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2027-2032) Table 32. Global Anti-inflammatory Therapeutics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Anti-inflammatory Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Anti-inflammatory Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2021-2026) Table 36. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2027-2032) Table 37. AbbVie Company Information Table 38. AbbVie Business Overview Table 39. AbbVie Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. AbbVie Anti-inflammatory Therapeutics Product Portfolio Table 41. AbbVie Recent Development Table 42. Johnson & Johnson Company Information Table 43. Johnson & Johnson Business Overview Table 44. Johnson & Johnson Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Johnson & Johnson Anti-inflammatory Therapeutics Product Portfolio Table 46. Johnson & Johnson Recent Development Table 47. Amgen Inc Company Information Table 48. Amgen Inc Business Overview Table 49. Amgen Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Amgen Inc Anti-inflammatory Therapeutics Product Portfolio Table 51. Amgen Inc Recent Development Table 52. AstraZeneca PLC Company Information Table 53. AstraZeneca PLC Business Overview Table 54. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. AstraZeneca PLC Anti-inflammatory Therapeutics Product Portfolio Table 56. AstraZeneca PLC Recent Development Table 57. Pfizer, Inc Company Information Table 58. Pfizer, Inc Business Overview Table 59. Pfizer, Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Pfizer, Inc Anti-inflammatory Therapeutics Product Portfolio Table 61. Pfizer, Inc Recent Development Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Novartis Anti-inflammatory Therapeutics Product Portfolio Table 66. Novartis Recent Development Table 67. Roche Company Information Table 68. Roche Business Overview Table 69. Roche Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Roche Anti-inflammatory Therapeutics Product Portfolio Table 71. Roche Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Merck Anti-inflammatory Therapeutics Product Portfolio Table 76. Merck Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Sanofi Anti-inflammatory Therapeutics Product Portfolio Table 81. Sanofi Recent Development Table 82. GlaxoSmithKline Company Information Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. GlaxoSmithKline Anti-inflammatory Therapeutics Product Portfolio Table 86. GlaxoSmithKline Recent Development Table 87. Sun Pharmaceutical Industries Ltd Company Information Table 88. Sun Pharmaceutical Industries Ltd Business Overview Table 89. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Portfolio Table 91. Sun Pharmaceutical Industries Ltd Recent Development Table 92. TEVA Company Information Table 93. TEVA Business Overview Table 94. TEVA Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. TEVA Anti-inflammatory Therapeutics Product Portfolio Table 96. TEVA Recent Development Table 97. North America Anti-inflammatory Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 98. North America Anti-inflammatory Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 99. North America Anti-inflammatory Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 100. North America Anti-inflammatory Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 101. North America Anti-inflammatory Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Anti-inflammatory Therapeutics Market Size by Country (2021-2026) Table 103. North America Anti-inflammatory Therapeutics Market Size by Country (2027-2032) Table 104. Europe Anti-inflammatory Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 105. Europe Anti-inflammatory Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 106. Europe Anti-inflammatory Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 107. Europe Anti-inflammatory Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 108. Europe Anti-inflammatory Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Anti-inflammatory Therapeutics Market Size by Country (2021-2026) Table 110. Europe Anti-inflammatory Therapeutics Market Size by Country (2027-2032) Table 111. China Anti-inflammatory Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 112. China Anti-inflammatory Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 113. China Anti-inflammatory Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 114. China Anti-inflammatory Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Anti-inflammatory Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 116. Asia Anti-inflammatory Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 117. Asia Anti-inflammatory Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 118. Asia Anti-inflammatory Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 119. Asia Anti-inflammatory Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Anti-inflammatory Therapeutics Market Size by Country (2021-2026) Table 121. Asia Anti-inflammatory Therapeutics Market Size by Country (2027-2032) Table 122. South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2021-2026) Table 128. South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Anti-inflammatory Therapeutics Product Image Figure 2. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Anti-inflammatory Therapeutics Market Share by Type: 2025 VS 2032 Figure 4. Anti-inflammatory Biologics Image Figure 5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Image Figure 6. Corticosteroids Image Figure 7. Others Image Figure 8. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Anti-inflammatory Therapeutics Market Share by Application: 2025 VS 2032 Figure 10. Arthritis Image Figure 11. Respiratory Diseases Image Figure 12. Dermatology Image Figure 13. Gastroenterology Image Figure 14. Others Image Figure 15. Global Anti-inflammatory Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 17. Global Anti-inflammatory Therapeutics Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Anti-inflammatory Therapeutics Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Anti-inflammatory Therapeutics Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Anti-inflammatory Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2021-2032) Figure 24. Global Anti-inflammatory Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2021-2032) Figure 26. North America Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 27. North America Anti-inflammatory Therapeutics Market Share by Type (2021-2032) Figure 28. North America Anti-inflammatory Therapeutics Market Share by Application (2021-2032) Figure 29. North America Anti-inflammatory Therapeutics Market Share by Country (2021-2032) Figure 30. United States Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 31. Canada Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 33. Europe Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 34. Europe Anti-inflammatory Therapeutics Market Share by Type (2021-2032) Figure 35. Europe Anti-inflammatory Therapeutics Market Share by Application (2021-2032) Figure 36. Europe Anti-inflammatory Therapeutics Market Share by Country (2021-2032) Figure 37. Germany Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 38. France Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 40. Italy Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 41. Russia Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 43. China Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 44. China Anti-inflammatory Therapeutics Market Share by Type (2021-2032) Figure 45. China Anti-inflammatory Therapeutics Market Share by Application (2021-2032) Figure 46. Asia Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 47. Asia Anti-inflammatory Therapeutics Market Share by Type (2021-2032) Figure 48. Asia Anti-inflammatory Therapeutics Market Share by Application (2021-2032) Figure 49. Asia Anti-inflammatory Therapeutics Market Share by Country (2021-2032) Figure 50. Japan Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 54. India Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 55. Australia Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Anti-inflammatory Therapeutics Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Anti-inflammatory Therapeutics Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Anti-inflammatory Therapeutics Market Share by Country (2021-2032) Figure 60. Brazil Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 65. UAE Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 67. Chile Anti-inflammatory Therapeutics Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-inflammatory Biologics
  • Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Others
Applications
  • Arthritis
  • Respiratory Diseases
  • Dermatology
  • Gastroenterology
  • Others
Companies covered
  • AbbVie
  • Johnson & Johnson
  • Amgen Inc
  • AstraZeneca PLC
  • Pfizer, Inc
  • Novartis
  • Roche
  • Merck
  • Sanofi
  • GlaxoSmithKline
  • Sun Pharmaceutical Industries Ltd
  • TEVA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Anti-inflammatory Biologics
  5. 1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6. 1.2.4 Corticosteroids
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Arthritis
  11. 1.3.3 Respiratory Diseases
  12. 1.3.4 Dermatology
  13. 1.3.5 Gastroenterology
  14. 1.3.6 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Anti-inflammatory Therapeutics Growth Trends by Region
  17. 1.5.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Anti-inflammatory Therapeutics Market Size by Region (2021-2026)
  19. 1.5.3 Anti-inflammatory Therapeutics Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Anti-inflammatory Therapeutics Market Dynamics
  1. 2.1 Anti-inflammatory Therapeutics Industry Trends
  2. 2.2 Anti-inflammatory Therapeutics Industry Drivers
  3. 2.3 Anti-inflammatory Therapeutics Industry Opportunities and Challenges
  4. 2.4 Anti-inflammatory Therapeutics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Anti-inflammatory Therapeutics Revenue by Company (2021-2026)
  2. 3.2 Global Anti-inflammatory Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Anti-inflammatory Therapeutics Key Company Head office and Area Served
  4. 3.4 Global Anti-inflammatory Therapeutics Company, Product Type & Application
  5. 3.5 Global Anti-inflammatory Therapeutics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Anti-inflammatory Therapeutics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Anti-inflammatory Therapeutics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Anti-inflammatory Therapeutics Tier 1, Tier 2, and Tier 3
4 Anti-inflammatory Therapeutics Market by Type
  1. 4.1 Global Anti-inflammatory Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Anti-inflammatory Therapeutics Market Size by Type (2021-2032)
  3. 4.3 Global Anti-inflammatory Therapeutics Market Size Share by Type (2021-2032)
5 Anti-inflammatory Therapeutics Market by Application
  1. 5.1 Global Anti-inflammatory Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Anti-inflammatory Therapeutics Market Size by Application (2021-2032)
  3. 5.3 Global Anti-inflammatory Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AbbVie
  2. 6.1.1 AbbVie Company Information
  3. 6.1.2 AbbVie Business Overview
  4. 6.1.3 AbbVie Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AbbVie Anti-inflammatory Therapeutics Product Portfolio
  6. 6.1.5 AbbVie Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Amgen Inc
  14. 6.3.1 Amgen Inc Company Information
  15. 6.3.2 Amgen Inc Business Overview
  16. 6.3.3 Amgen Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Amgen Inc Anti-inflammatory Therapeutics Product Portfolio
  18. 6.3.5 Amgen Inc Recent Developments
  19. 6.4 AstraZeneca PLC
  20. 6.4.1 AstraZeneca PLC Company Information
  21. 6.4.2 AstraZeneca PLC Business Overview
  22. 6.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Product Portfolio
  24. 6.4.5 AstraZeneca PLC Recent Developments
  25. 6.5 Pfizer, Inc
  26. 6.5.1 Pfizer, Inc Company Information
  27. 6.5.2 Pfizer, Inc Business Overview
  28. 6.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Product Portfolio
  30. 6.5.5 Pfizer, Inc Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis Anti-inflammatory Therapeutics Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Roche Anti-inflammatory Therapeutics Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 Merck
  44. 6.8.1 Merck Company Information
  45. 6.8.2 Merck Business Overview
  46. 6.8.3 Merck Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Merck Anti-inflammatory Therapeutics Product Portfolio
  48. 6.8.5 Merck Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sanofi Anti-inflammatory Therapeutics Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
  55. 6.10 GlaxoSmithKline
  56. 6.10.1 GlaxoSmithKline Company Information
  57. 6.10.2 GlaxoSmithKline Business Overview
  58. 6.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Product Portfolio
  60. 6.10.5 GlaxoSmithKline Recent Developments
  61. 6.11 Sun Pharmaceutical Industries Ltd
  62. 6.11.1 Sun Pharmaceutical Industries Ltd Company Information
  63. 6.11.2 Sun Pharmaceutical Industries Ltd Business Overview
  64. 6.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Portfolio
  66. 6.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
  67. 6.12 TEVA
  68. 6.12.1 TEVA Company Information
  69. 6.12.2 TEVA Business Overview
  70. 6.12.3 TEVA Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 TEVA Anti-inflammatory Therapeutics Product Portfolio
  72. 6.12.5 TEVA Recent Developments
7 North America
  1. 7.1 North America Anti-inflammatory Therapeutics Market Size (2021-2032)
  2. 7.2 North America Anti-inflammatory Therapeutics Market Size by Type
  3. 7.2.1 North America Anti-inflammatory Therapeutics Market Size by Type (2021-2026)
  4. 7.2.2 North America Anti-inflammatory Therapeutics Market Size by Type (2027-2032)
  5. 7.2.3 North America Anti-inflammatory Therapeutics Market Share by Type (2021-2032)
  6. 7.3 North America Anti-inflammatory Therapeutics Market Size by Application
  7. 7.3.1 North America Anti-inflammatory Therapeutics Market Size by Application (2021-2026)
  8. 7.3.2 North America Anti-inflammatory Therapeutics Market Size by Application (2027-2032)
  9. 7.3.3 North America Anti-inflammatory Therapeutics Market Share by Application (2021-2032)
  10. 7.4 North America Anti-inflammatory Therapeutics Market Size by Country
  11. 7.4.1 North America Anti-inflammatory Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
  13. 7.4.3 North America Anti-inflammatory Therapeutics Market Size by Country (2027-2032)
  14. 7.4.4 North America Anti-inflammatory Therapeutics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Anti-inflammatory Therapeutics Market Size (2021-2032)
  2. 8.2 Europe Anti-inflammatory Therapeutics Market Size by Type
  3. 8.2.1 Europe Anti-inflammatory Therapeutics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Anti-inflammatory Therapeutics Market Share by Type (2021-2032)
  6. 8.3 Europe Anti-inflammatory Therapeutics Market Size by Application
  7. 8.3.1 Europe Anti-inflammatory Therapeutics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Anti-inflammatory Therapeutics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Anti-inflammatory Therapeutics Market Share by Application (2021-2032)
  10. 8.4 Europe Anti-inflammatory Therapeutics Market Size by Country
  11. 8.4.1 Europe Anti-inflammatory Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Anti-inflammatory Therapeutics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Anti-inflammatory Therapeutics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Anti-inflammatory Therapeutics Market Size (2021-2032)
  2. 9.2 China Anti-inflammatory Therapeutics Market Size by Type
  3. 9.2.1 China Anti-inflammatory Therapeutics Market Size by Type (2021-2026)
  4. 9.2.2 China Anti-inflammatory Therapeutics Market Size by Type (2027-2032)
  5. 9.2.3 China Anti-inflammatory Therapeutics Market Share by Type (2021-2032)
  6. 9.3 China Anti-inflammatory Therapeutics Market Size by Application
  7. 9.3.1 China Anti-inflammatory Therapeutics Market Size by Application (2021-2026)
  8. 9.3.2 China Anti-inflammatory Therapeutics Market Size by Application (2027-2032)
  9. 9.3.3 China Anti-inflammatory Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Anti-inflammatory Therapeutics Market Size (2021-2032)
  2. 10.2 Asia Anti-inflammatory Therapeutics Market Size by Type
  3. 10.2.1 Asia Anti-inflammatory Therapeutics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Anti-inflammatory Therapeutics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Anti-inflammatory Therapeutics Market Share by Type (2021-2032)
  6. 10.3 Asia Anti-inflammatory Therapeutics Market Size by Application
  7. 10.3.1 Asia Anti-inflammatory Therapeutics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Anti-inflammatory Therapeutics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Anti-inflammatory Therapeutics Market Share by Application (2021-2032)
  10. 10.4 Asia Anti-inflammatory Therapeutics Market Size by Country
  11. 10.4.1 Asia Anti-inflammatory Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Anti-inflammatory Therapeutics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Anti-inflammatory Therapeutics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Anti-inflammatory Therapeutics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst